Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that OpenAI Chief Executive Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro. […]
The post Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences appeared first on SiliconANGLE.
发布者：Maria Deutscher，转转请注明出处：https://robotalks.cn/sam-altman-reportedly-backs-1b-round-for-ai-healthcare-startup-retro-biosciences/
